Skip to main content
  • EN
  • FI
  • SV
Login

Main navigation

  • About FinnGen
    • Summary & Goals
      • Goals
      • FinnGen 1-2
      • FinnGen 3 (2023-2027)
    • Consortium
      • Partners
      • Funding
      • Governance
      • Steering Committee Members
      • Scientific Committee Members
      • Teams
      • Collaboration
    • Impact
      • National Impact
      • National Research Network
      • Open Science
      • Research Highlights
    • Why Finland?
      • Biobank Network
      • Legislative Review
      • National Registries
      • Population Genetic History
      • Industry partners
    • Mediabank
  • For Researchers
    • Research Activities
      • Core Analyses
      • Disease Task Forces
      • Expansion Areas
      • Global Initiatives
    • Cohort and Data
      • Register Data
      • Basic Characteristics
      • Clinical Endpoints
      • Genetic Data
      • Laboratory Values
      • Other Phenotype Data
      • Recruitment
      • Other Biological Data
      • Data Available
    • Accessing Data, Results & Tools
      • Access results
      • Computing environment
      • How We Collaborate
      • Partner researchers
      • Public data releases
      • Tools
    • Publications
    • Researcher FAQ
  • For Participants
    • Participation
      • Study Participants
      • Biobanks' Role in FinnGen
      • Biobank Contact Information
      • Recall Studies
      • Questions and answers
    • Data Protection and Security
      • Data Protection
      • Data Security
      • Sample & Data Flow
      • Data Protection Statement
    • Significance
      • Videos
  • News
  • EN
  • FI
  • SV

Links

  • PheWeb
  • Risteys
  • Meta-analysis Pheweb (FG-MVP-UKBB)
  • FinnGen handbook
  • Meta-analysis Pheweb (FG-UKBB)
  • Coding variant browser
  • Endpoint Browser
  • FinnGen GITHUB
  • LAVAA volcano plot
  • Multiple Manhattan Plot
  • Variant Cluster Corrector
  • Variant Cluster Call Corrector
Breadcrumb
  1. Home

SGLT2 Inhibition, Choline Metabolites, and Cardiometabolic Diseases: A Mediation Mendelian Randomization Study

Submitted by Frida Mäkelä on Mon, 11/21/2022 - 09:28
  • Read more about SGLT2 Inhibition, Choline Metabolites, and Cardiometabolic Diseases: A Mediation Mendelian Randomization Study

Causal effects of gut microbiota on diabetic retinopathy: A Mendelian randomization study

Submitted by Frida Mäkelä on Mon, 11/21/2022 - 09:22
  • Read more about Causal effects of gut microbiota on diabetic retinopathy: A Mendelian randomization study

The causal association of polyunsaturated fatty acids with allergic disease: A two-sample Mendelian randomization study

Submitted by Frida Mäkelä on Mon, 11/21/2022 - 09:16
  • Read more about The causal association of polyunsaturated fatty acids with allergic disease: A two-sample Mendelian randomization study

No causal effect of tea consumption on cardiovascular diseases: A two-sample Mendelian randomization study

Submitted by Frida Mäkelä on Mon, 11/21/2022 - 09:03
  • Read more about No causal effect of tea consumption on cardiovascular diseases: A two-sample Mendelian randomization study

Childhood asthma and type 1 diabetes mellitus: A meta-analysis and bidirectional Mendelian randomization study

Submitted by Frida Mäkelä on Fri, 11/18/2022 - 16:08
  • Read more about Childhood asthma and type 1 diabetes mellitus: A meta-analysis and bidirectional Mendelian randomization study

Morning chronotype and digestive tract cancers: Mendelian randomization study

Submitted by Frida Mäkelä on Fri, 11/18/2022 - 15:52
  • Read more about Morning chronotype and digestive tract cancers: Mendelian randomization study

Screening for potential undiagnosed Gaucher disease patients: Utilisation of the Gaucher earlier diagnosis consensus point-scoring system (GED-C PSS) in conjunction with electronic health record data, tissue specimens, and small nucleotide polymorphism (SNP) genotype data available in Finnish biobanks

Submitted by Frida Mäkelä on Fri, 11/18/2022 - 15:43
  • Read more about Screening for potential undiagnosed Gaucher disease patients: Utilisation of the Gaucher earlier diagnosis consensus point-scoring system (GED-C PSS) in conjunction with electronic health record data, tissue specimens, and small nucleotide polymorphism (SNP) genotype data available in Finnish biobanks

A pleiotropic variant in DNAJB4 is associated with multiple myeloma risk

Submitted by Frida Mäkelä on Fri, 11/18/2022 - 15:38
  • Read more about A pleiotropic variant in DNAJB4 is associated with multiple myeloma risk

Circulating adipokine levels and preeclampsia: A bidirectional Mendelian randomization study

Submitted by Frida Mäkelä on Fri, 11/18/2022 - 15:36
  • Read more about Circulating adipokine levels and preeclampsia: A bidirectional Mendelian randomization study

Coffee and caffeine consumption and risk of renal cell carcinoma: A Mendelian randomization study

Submitted by Frida Mäkelä on Fri, 11/18/2022 - 15:23
  • Read more about Coffee and caffeine consumption and risk of renal cell carcinoma: A Mendelian randomization study

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 375
  • Page 376
  • Page 377
  • Page 378
  • Current page 379
  • Page 380
  • Page 381
  • Page 382
  • Page 383
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Contact us

Contact person
finngen-info@helsinki.fi
Follow us on Bluesky
@finngen.bsky.social

Lead organisations

The University of Helsinki is the organization responsible for the FinnGen research project. The Finnish consortium partners include all Finnish public biobanks and their background organisations, so the project covers the whole of Finland. All partners are listed on this page.

About the website

Accessibility statement